These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5148725)

  • 41. Activity of delta8- and delta9-tetrahydrocannabinol and related compounds in the mouse.
    Christensen HD; Freudenthal RI; Gidley JT; Rosenfeld R; Boegli G; Testino L; Brine DR; Pitt CG; Wall ME
    Science; 1971 Apr; 172(3979):165-7. PubMed ID: 5547729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma protein binding of 7-hydroxy- 1-tetrahydrocannabinol: an active 1-tetrahydrocannabinol metabolite.
    Widman M; Nilsson IM; Agurell S; Borg H; Granstrand B
    J Pharm Pharmacol; 1973 Jun; 25(6):453-7. PubMed ID: 4146583
    [No Abstract]   [Full Text] [Related]  

  • 43. 6 -hydroxy- 1 -tetrahydrocannabinol synthesis and biological activity.
    Ben-Zvi Z; Mechoulam R; Edery H; Porath G
    Science; 1971 Nov; 174(4012):951-2. PubMed ID: 5001309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis of a potential urinary tetrahydrocannabinol metabolite.
    Nilsson JL; Nilsson IM; Agurell S; Ben-Zvi Z; Mechoulam R
    Acta Pharm Suec; 1972 Jun; 9(3):215-20. PubMed ID: 5053671
    [No Abstract]   [Full Text] [Related]  

  • 45. Distribution of delta 9-tetrahydrocannabinol in the mouse.
    Freudenthal RI; Martin J; Wall ME
    Br J Pharmacol; 1972 Feb; 44(2):244-9. PubMed ID: 4668591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Marihuana metabolites in urine of man. II. Undescribed metabolite following oral ingestion of delta-9-tetrahydrocannabinol.
    Kanter SL; Hollister LE; Moore F; Green DE
    Res Commun Chem Pathol Pharmacol; 1974 Jan; 7(1):79-84. PubMed ID: 4811461
    [No Abstract]   [Full Text] [Related]  

  • 47. Physiochemical properties, solubility, and protein binding of delta9-tetrahydrocannabinol.
    Garrett ER; Hunt CA
    J Pharm Sci; 1974 Jul; 63(7):1056-64. PubMed ID: 4853640
    [No Abstract]   [Full Text] [Related]  

  • 48. Metabolism of cannabis. IX. Cannabinol: structure of a major metabolite formed in rat liver.
    Widman M; Nilsson IM; Nilsson JL; Agurell S; Leander K
    Life Sci II; 1971 Feb; 10(3):157-62. PubMed ID: 5575428
    [No Abstract]   [Full Text] [Related]  

  • 49. Fluorescence of cannabinoids.
    Dienyssiou-Asteriou A; Miras CJ
    J Pharm Pharmacol; 1975 Feb; 27(2):135-6. PubMed ID: 237076
    [No Abstract]   [Full Text] [Related]  

  • 50. Semi-quantitative thin-layer mass-screening detection of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in human urine.
    Kaistha KK; Tadrus R
    J Chromatogr; 1982 Mar; 237(3):528-33. PubMed ID: 6284774
    [No Abstract]   [Full Text] [Related]  

  • 51. Detection of delta 9-tetrahydrocannabinol in saliva of men by means of thin-layer chromatography and mass spectrometry.
    Just WW; Filipovic N; Werner G
    J Chromatogr; 1974 Sep; 96(2):189-94. PubMed ID: 4412740
    [No Abstract]   [Full Text] [Related]  

  • 52. [Problems concerning the reliable identification of hashish in urine by thin-layer chromatography].
    Salaschek M; Matte A; Seifert R
    J Chromatogr; 1973 Apr; 78(2):393-400. PubMed ID: 4700471
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects on humans of 9 -tetrahydrocannabinol administered by smoking.
    Galanter M; Wyatt RJ; Lemberger L; Weingartner H; Vaughan TB; Roth WT
    Science; 1972 May; 176(4037):934-6. PubMed ID: 4555981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Growth and metabolites of Cannabis sativa cell suspension cultures.
    Veliky IA; Genest K
    Lloydia; 1972 Dec; 35(4):450-6. PubMed ID: 4660513
    [No Abstract]   [Full Text] [Related]  

  • 55. Delta-1-tetrahydrocannabinol: structure of a major metabolite.
    Nilsson IM; Agurell S; Nilsson JL; Ohlsson A; Sandberg F; Wahlqvist M
    Science; 1970 Jun; 168(3936):1228-9. PubMed ID: 5442709
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subchronic oral doses of marihuana extract.
    Hollister LE; Tinklenberg JR
    Psychopharmacologia; 1973; 29(3):247-52. PubMed ID: 4702276
    [No Abstract]   [Full Text] [Related]  

  • 57. Picogram analysis of tetrahydrocannabinol and application to biological fluids.
    Garrett ER; Hunt CA
    J Pharm Sci; 1973 Jul; 62(7):1211-4. PubMed ID: 4714142
    [No Abstract]   [Full Text] [Related]  

  • 58. Confirmation of cannabis use. III. Simultaneous quantitation of six metabolites of delta 9-tetrahydrocannabinol in plasma by high-performance liquid chromatography with electrochemical detection.
    Nakahara Y; Cook CE
    J Chromatogr; 1988 Dec; 434(1):247-52. PubMed ID: 2854134
    [No Abstract]   [Full Text] [Related]  

  • 59. Delta9-tetrahydrocannabinol-uptake by rat liver lysosomes.
    Irvin JE; Mellors A
    Biochem Pharmacol; 1975 Jan; 24(2):305-7. PubMed ID: 1111544
    [No Abstract]   [Full Text] [Related]  

  • 60. Cannabinoids in the urine of man after single and subchronic oral doses of marihuana.
    Kanter SL; Hollister LE; Moore F; Green D
    Int Pharmacopsychiatry; 1972; 7(1-4):205-13. PubMed ID: 4619398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.